Evaluation of the Biosafety of lead substitutes Used in the Manufacture of Unleaded Crystal Glass

Project Information

Grant agreement ID: BRST950030

Project closed

Start date 27 July 1995

End date 12 June 1996

Funded under

• Specific research and technological development programme in the field of industrial and materials technologies, 1994-1998

Total cost € 0,00

EU contribution No data

Coordinated by

Royal Brierley Crystal
United Kingdom

Objective

Currently crystal glass contains either 24% or 32% lead. In use, lead may leach from crystal into liquids which may be subsequently drunk, resulting in lead intake by the general public. This intake is regarded as unacceptable by groups in some countries (e.g. USA) and therefore there is pressure to remove lead from crystal and replace it with G safer substitute. Whilst a lot is known about lead toxicity, relatively little is known the bioavailability, toxicity and behaviour of substitutes in the body The aim of the project is to provide the European Crystal Industry with the biological information for the production of a safety case for genetic unleaded crystal compositions.

Fields of science

• engineering and technology › materials engineering

Programme(s)

• FP4-BRITE/EURAM 3 - Specific research and technological development programme in the field of industrial and materials technologies, 1994-1998

Topic(s)

• 0102 - Development of clean production technologies

Call for proposal

Data not available

Funding Scheme

EAW - Exploratory awards

Coordinator

Royal Brierley Crystal

• EU contribution: No data
• Address: North Street ; DY5 3SJ Brierley Hill ; United Kingdom
• Total cost: No data